Marktkapitalisierung Veränderung Datum
Alcon AG USD 30.94B 4.85B 2026-11
Almirall EUR 2.28B 168.06M 2026-11
Amarin USD 290M 51M 2025-12
argenx SE USD 60.01B 2.38B 2026-09
AstraZeneca USD 213.88B 23.43B 2026-11
Bayer EUR 52.42B 5.31B 2026-11
Genmab DKK 17.1B 88.06B 2026-06
GlaxoSmithKline GBP 74.11B 6.03B 2026-09
GRIFOLS EUR 4.76B 1.02B 2026-11
Hikma Pharmaceutical USD 4.63B 1.42B 2025-12
Lakefront Biotherapeutics EUR 2.07B 333.44M 2026-11
Lonza CHF 39.68B 980.61M 2025-06
Merck EUR 64.74B 46.89B 2026-11
Novartis USD 292.09B 51.5B 2026-09
Recordati EUR 10.93B 82.06M 2026-11
Roche Holding CHF 270B 3.66B 2026-06
Sanofi EUR 100.56B 13.53B 2026-11
UCB EUR 46.41B 13.94B 2025-12
Unibail Rodamco EUR 13.3B 1.68B 2025-12